辅酶Q10缺乏相关肾小球病的临床谱与基因型-表型关联变异
该研究通过系统文献综述、PodoNet、mitoNET和CCGKDD登记查询及在线调查,收集了251例辅酶Q10缺乏相关肾小球病患者的临床与遗传数据,其中173例已发表(47例更新)和78例新病例。研究发现不同致病基因变异患者肾脏病诊断年龄、肾外表现及肾脏存活率存在差异,并观察到显著的家系内和家系间表型变异。
要点
- COQ2、COQ6和COQ8B变异患者肾脏病诊断中位年龄分别为1.0年、1.2年和9.8年。
- COQ6变异患者中,激素抵抗型肾病综合征合并感音神经性听力损失为特征性表型。
- COQ8B变异患者至5岁无进展至肾衰竭,而COQ2和COQ6变异患者50%进展至肾衰竭。
核心结论
- 辅酶Q10缺乏相关肾小球病存在显著的基因型-表型关联及家系内和家系间表型变异,提示遗传和非遗传修饰因素影响疾病严重程度。
研究设计与样本
- 研究类型为系统文献综述、登记查询和在线调查,纳入251例患者,包括173例已发表(47例更新)和78例新病例。
主要发现
- 肾脏病首次诊断中位年龄在COQ2、COQ6和COQ8B变异个体分别为1.0年、1.2年和9.8年。
- 诊断时孤立肾脏受累在COQ2变异个体占34%,COQ6变异个体占10.8%,COQ8B变异个体占70.7%。
- COQ2变异队列中22%表现为经典婴儿多器官受累,47%在中位年龄2.7年出现神经系统症状。
- COQ6变异患者中,激素抵抗型肾病综合征合并感音神经性听力损失被确认为特征性表型,听力损害平均出现年龄为3岁。
- 至5岁时,COQ8B变异患者无进展至肾衰竭,而COQ2和COQ6变异患者50%进展至肾衰竭;成年期所有疾病肾脏存活率均低(20-25%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Primary Coenzyme Q10 deficiency is a rare mitochondriopathy with a wide spectrum of organ involvement, including steroid-resistant nephrotic syndrome mainly associated with disease-causing variants in the genes COQ2, COQ6 or COQ8B. We performed a systematic literature review, PodoNet, mitoNET, and CCGKDD registries queries and an online survey, collecting comprehensive clinical and genetic data of 251 patients spanning 173 published (47 updated) and 78 new cases. Kidney disease was first diagnosed at median age 1.0, 1.2 and 9.8 years in individuals with disease-causing variants in COQ2, COQ6 and COQ8B, respectively. Isolated kidney involvement at diagnosis occurred in 34% of COQ2, 10.8% of COQ6 and 70.7% of COQ8B variant individuals. Classic infantile multiorgan involvement comprised 22% of the COQ2 variant cohort while 47% of them developed neurological symptoms at median age 2.7 years. The association of steroid-resistant nephrotic syndrome and sensorineural hearing loss was confirmed as the distinctive phenotype of COQ6 variants, with hearing impairment manifesting at average age three years. None of the patients with COQ8B variants, but 50% of patients with COQ2 and COQ6 variants progressed to kidney failure by age five. At adult age, kidney survival was equally poor (20-25%) across all disorders. A number of sequence variants, including putative local founder mutations, had divergent clinical presentations, in terms of onset age, kidney and non-kidney manifestations and kidney survival. Milder kidney phenotype was present in those with biallelic truncating variants within the COQ8B variant cohort. Thus, significant intra- and inter-familial phenotype variability was observed, suggesting both genetic and non-genetic modifiers of disease severity.
引用
- Drovandi S, Lipska-Ziętkiewicz BS, Ozaltin F, et al. Variation of the clinical spectrum and genotype-phenotype associations in Coenzyme Q10 deficiency associated glomerulopathy. Kidney Int. 2022. PMID: 35483523. doi:10.1016/j.kint.2022.02.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。